Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2009 (2009), Article ID 963506, 12 pages
http://dx.doi.org/10.1155/2009/963506
Research Article

Comorbidities of Idiopathic Thrombocytopenic Purpura: A Population-Based Study

1Worldwide Epidemiology, GlaxoSmithKline R & D, Greenford, Middlesex, UB6 0HE, UK
2Institut National de la Statistique et de l’Analyse Economique (INSAE), Campus de Ker Lann, rue Blaise Pascal, BP 37203, Bruz Cedex 35172, France
3Worldwide Epidemiology, GlaxoSmithKline R & D, Five Moore Drive, Research Triangle Park, NC 27709, USA
4Worldwide Epidemiology, GlaxoSmithKline R & D, Greenford, Middlesex UB6 0HE, UK
5Pharma Development Safety, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland

Received 10 October 2008; Accepted 1 December 2008

Academic Editor: Simon Karpatkin

Copyright © 2009 M. A. Feudjo-Tepie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. B. Cines and V. S. Blanchette, “Immune thrombocytopenic purpura,” The New England Journal of Medicine, vol. 346, no. 13, pp. 995–1008, 2002. View at Publisher · View at Google Scholar · View at PubMed
  2. R. McMillan, L. Wang, A. Tomer, J. Nichol, and J. Pistillo, “Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP,” Blood, vol. 103, no. 4, pp. 1364–1369, 2004. View at Publisher · View at Google Scholar · View at PubMed
  3. Y. C. Cohen, B. Djuibegovic, O. Shamai-Lubovitz, and B. Mozes, “The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts,” Archives of Internal Medicine, vol. 160, no. 11, pp. 1630–1638, 2000. View at Publisher · View at Google Scholar
  4. “Idiopathic Thrombocytopenic Purpura,” Lucile Packard Children's Hospital, 2006, http://www.lpch.org/DiseaseHealthInfo/HealthLibrary/hematology/bledidio.html.
  5. Guideline, “Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy,” British Journal of Haematology, vol. 120, no. 4, pp. 574–596, 2003. View at Publisher · View at Google Scholar
  6. J. N. George, S. H. Woolf, J. S. Wasser et al., “Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology,” Annals of Internal Medicine, vol. 126, no. 4, pp. 319–326, 1997. View at Google Scholar
  7. H. Frederiksen and K. Schmidt, “The incidence of idiopathic thrombocytopenic purpura in adults increases with age,” Blood, vol. 94, no. 3, pp. 909–913, 1999. View at Google Scholar
  8. J. B. Segal and N. R. Powe, “Prevalence of immune thrombocytopenia: analyses of administrative data,” Journal of Thrombosis and Haemostasis, vol. 4, no. 11, pp. 2377–2383, 2006. View at Publisher · View at Google Scholar · View at PubMed
  9. O. Landgren, G. Gridley, T. R. Fears, and N. Caporaso, “Immune thrombocytopenic purpura does not exhibit a disparity in prevalence between African American and white veterans,” Blood, vol. 108, no. 3, pp. 1111–1112, 2006. View at Publisher · View at Google Scholar · View at PubMed
  10. M. A. Feudjo-Tepie, N. J. Robinson, and D. Bennett, “Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal,” Journal of Thrombosis and Haemostasis, vol. 6, no. 4, pp. 711–712, 2008. View at Publisher · View at Google Scholar · View at PubMed
  11. A. R. Feinstein, “The pre-therapeutic classification of co-morbidity in chronic disease,” Journal of Chronic Diseases, vol. 23, no. 7, pp. 455–468, 1970. View at Publisher · View at Google Scholar
  12. R. Bech-Azeddine, P. Høgh, M. Juhler, F. Gjerris, and G. Waldemar, “Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 2, pp. 157–161, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. A. R. Feinstein, C. R. Schimpff, J. F. Andrews, Jr., and C. K. Wells, “Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment,” Journal of Chronic Diseases, vol. 30, no. 5, pp. 277–305, 1977. View at Publisher · View at Google Scholar
  14. C. K. Wells, J. K. Stoller, A. R. Feinstein, and R. I. Horwitz, “Comorbid and clinical determinants of prognosis in endometrial cancer,” Archives of Internal Medicine, vol. 144, no. 10, pp. 2004–2009, 1984. View at Publisher · View at Google Scholar
  15. J. D. Clemens, A. R. Feinstein, N. Holabird, and S. Cartwright, “A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer,” Journal of Chronic Diseases, vol. 39, no. 11, pp. 913–928, 1986. View at Publisher · View at Google Scholar
  16. M. D. Miller, C. F. Paradis, P. R. Houck et al., “Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale,” Psychiatry Research, vol. 41, no. 3, pp. 237–248, 1992. View at Publisher · View at Google Scholar
  17. E. Waldman and J. F. Potter, “A prospective evaluation of the Cumulative Illness Rating Scale,” Aging, vol. 4, no. 2, pp. 171–178, 1992. View at Google Scholar
  18. B. Singh, M. Bhaya, J. Stern et al., “Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study,” Laryngoscope, vol. 107, no. 11, part 1, pp. 1469–1475, 1997. View at Publisher · View at Google Scholar
  19. B. Colinet, W. Jacot, D. Bertrand et al., “A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index,” British Journal of Cancer, vol. 93, no. 10, pp. 1098–1105, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. H. Jick, S. S. Jick, and L. E. Derby, “Validation of information recorded on general practitioner based computerised data resource in the United Kingdom,” British Medical Journal, vol. 302, no. 6779, pp. 766–768, 1991. View at Google Scholar
  21. L. A. García Rodríguez and S. Pérez Gutthann, “Use of the UK General Practice Research Database for pharmacoepidemiology,” British Journal of Clinical Pharmacology, vol. 45, no. 5, pp. 419–425, 1998. View at Publisher · View at Google Scholar
  22. J. B. Soriano, G. T. Visick, H. Muellerova, N. Payvandi, and A. L. Hansell, “Patterns of comorbidities in newly diagnosed COPD and asthma in primary care,” Chest, vol. 128, no. 4, pp. 2099–2107, 2005. View at Publisher · View at Google Scholar · View at PubMed
  23. D. H. Lawson, V. Sherman, and J. Hollowell, “The General Practice Research Database. Scientific and Ethical Advisory Group,” QJM, vol. 91, no. 6, pp. 445–452, 1998. View at Publisher · View at Google Scholar
  24. I. Nazareth, M. King, A. Haines, L. Rangel, and S. Myers, “Accuracy of diagnosis of psychosis on general practice computer system,” British Medical Journal, vol. 307, no. 6895, pp. 32–34, 1993. View at Google Scholar
  25. H. Jick, B. Z. Terris, L. E. Derby, and S. S. Jick, “Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom,” Pharmacoepidemiol Drug Safety, vol. 1, no. 6, pp. 347–349, 1992. View at Publisher · View at Google Scholar
  26. S. S. Jick, J. A. Kaye, C. Vasilakis-Scaramozza et al., “Validity of the general practice research database,” Pharmacotherapy, vol. 23, no. 5, pp. 686–689, 2003. View at Publisher · View at Google Scholar
  27. V. Kiri, H. Muellerova, and G. Visick, “Trends in the diagnosis of lung cancer in the UK primary care system: is the health service failing the population at risk?,” in AM J Respir Crit Care Med, 2:A120, 2005.
  28. A. Agresti, An Introduction to Categorical Data Analysis, John Wiley & Sons, New York, NY, USA, 1996.
  29. Y. Benjamini and D. Yekutieli, “The control of the false discovery rate in multiple testing under dependency,” Annals of Statistics, vol. 29, no. 4, pp. 1165–1188, 2001. View at Publisher · View at Google Scholar · View at MathSciNet
  30. D. Clayton and H. Michael, Statistical Models in Epidemiology, Oxford University Press, New York, NY, USA, 1993.
  31. N. E. Breslow and N. E. Day, Statistical Methods in Cancer Research. Vol. II. The Design and Analysis of Cohort Studies, IARC Scientific Publications, no. 82, International Agency for Research on Cancer, Lyon, France, 1987.
  32. L. Derby and W. C. Maier, “Risk of cataract among users of intranasal corticosteroids,” Journal of Allergy and Clinical Immunology, vol. 105, no. 5, pp. 912–916, 2000. View at Publisher · View at Google Scholar · View at PubMed
  33. S. Daou, L. Federici, J. Zimmer, F. Maloisel, K. Serraj, and E. Andrès, “Idiopathic thrombocytopenic purpura in elderly patients: a study of 47 cases from a single reference center,” European Journal of Internal Medicine, vol. 19, no. 6, pp. 447–451, 2008. View at Publisher · View at Google Scholar · View at PubMed
  34. M. Teesson, H. Proudfoot, and National Drug and Alcohol Research Centre, Eds., Comorbid Mental Disorders and Substance Use Disorders: Epidemiology, Prevention and Treatment, M. Teesson, H. Proudfoot, and National Drug and Alcohol Research Centre, Eds., University of Canberra, Canberra, Australia, 2004.